# A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

> **NCT04021173** · PHASE2 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 74 (estimated)

## Conditions studied

- Acquired Thrombotic Thrombocytopenic Purpura

## Interventions

- **DRUG:** Anfibatide
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04021173
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07
- **Primary completion:** 2021-07
- **Final completion:** 2021-11
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2019-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04021173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04021173, "A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04021173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*